Metformin is the most commonly used treatment to improve insulin sensitivity in insulin-resistant conditions such as diabetes, prediabetes, polycystic ovary syndrome, and obesity [38]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.